Navigation Links
Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
Date:7/29/2008

366) $(34,471)

Basic and diluted net

loss per share: ($0.34) ($0.41) ($0.70) ($0.61)

Shares used in

calculation of basic

and diluted net loss

per share: 56,359 56,170 56,316 56,148

(1) Stock-based compensation expenses included in operating expenses

amounted to approximately:

Research and development $467 $723 $1,127 $1,891

Selling, general and

administrative 876 1,296 1,755 2,533

IDENIX PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS)

(UNAUDITED)

June 30, December 31,

2008 2007

ASSETS

Cash and cash equivalents $ 54,062 $ 48,260

Marketable securities 16,270 39,862

Receivables from related party 1,727 11,196

Other current assets 3,221 4,401

Total current assets 75,280 103,719

Intangible asset, net 12,968 13,548

Property and equipment, net 14,873 15,460

Marketable securities, non-current 10,308 23,882

Other assets 3,852 3,931

Total assets $ 117,281 $ 160,540

LIABILITIES AND STOCKHOLDERS' EQUITY

Accounts payable and accrued expenses $ 15,953 $ 21,809

Deferred revenue, related party 7,766 8,372

Other current liabilities 64
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
2. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
3. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
5. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
6. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
7. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
8. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
9. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
10. Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP
11. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... White papers by Clinovo on CDISC ... have been published by leading pharmaceutical publications Data Basics ... of white papers by Clinovo to have been featured ... Online, and OpenHealthNews. , At the request of SCDM ... Desgrousilliers, 'The Five Essentials of Cloud Computing for ...
(Date:7/28/2014)... VA (PRWEB) July 28, 2014 The ... nonprofit authority on the use of health IT to ... Health Plan Identifier (HPID) Workgroup has developed ... a Health Plan and Payer?” The HPID Workgroup, a ... closely with the Centers for Medicare and Medicaid Services ...
(Date:7/28/2014)... -   JOLT , a leading technology accelerator, announced ... growing portfolio of startups. Next-level tech and boundary-pushing innovation ... JOLT accelerator, and Cohort four is no exception, with ... Since its launch in July 2012, JOLT has produced ... Now at 23 investments, JOLT,s portfolio has an overall ...
(Date:7/28/2014)... 2014 Appistry, Inc. , a ... the power of genomics to next-generation medicine, announced today ... Challenge . , Two Appistry staff will be ... Center for Genome Resources, and Mr. Neil Miller, director ... Kansas City. Rounding out the panel are Appistry’s Dr. ...
Breaking Biology Technology:Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 3WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 3Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2
... 15, 2011 BioNeutral Group, Inc. (OTC Bulletin ... science technology-based company, today announced that it has ... with Raymond Associates LLC, a Service Connected Certified ... Under the terms of the agreement, Raymond Associates ...
... DIEGO, March 14, 2011 OncoSec Medical, Inc. (OTC ... appointment of Mr. Punit Dhillon as president and chief ... (Logo:   http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) Mr. Dhillon ... the biotech industry. He was recently VP Finance & ...
... Technology, Inc. ("ACT"; OTC Bulletin Board: ACTC ... announced today that Gary Rabin, the company,s interim chairman ... BIO-Europe Spring 2011 Conference, March 14-16, at the Milano ... scheduled for Wednesday, March 16, at 10:15 a.m. CET, ...
Cached Biology Technology:BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM) 2BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM) 3BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM) 4ACT Interim Chairman and CEO Gary Rabin to Present at BIO-Europe Spring 2011 Conference 2
(Date:7/28/2014)... and other forms of dementia, but the research community ... of Washington bioengineers have a designed a peptide structure ... normal proteins into a state that,s linked to widespread ... diabetes and Lou Gehrig,s disease. The synthetic molecule blocks ... into an abnormally folded form by targeting a toxic ...
(Date:7/28/2014)... St. Jude Children,s Research Hospital study found that 73 ... doubled their risk of developing metabolic syndrome and related ... The results appear in the current issue of the ... the 1,598 adult survivors of childhood cancer in the ... risk factors like high blood pressure, abdominal obesity, elevated ...
(Date:7/28/2014)... Research and Markets has announced ... America 2014-2018" report to their offering. ... and analyze biological data. These systems capture biological traits ... patterns, and hand measurements from the subject and compare ... main purpose of a biometrics system is to identify ...
Breaking Biology News(10 mins):New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3Biometrics Market in Latin America 2014-2018 2
... Research Institute,s Drs. Peter Cadieux and Hassan Razvi have ... $2.2 million grant from the National Institutes of Health ... explore the potential of novel coatings to significantly reduce ... The grant was awarded in collaboration with Nerites ...
... beginning of the Industrial Revolution, the concentration of carbon dioxide ... of fossil fuels. Increased absorption of this carbon by the ... how acidic or basic a substance is) and aragonite saturation ... the mineral form of calcium carbonate that is laid down ...
... a unique fish that lives on land and can leap ... complex social life, a new study has found., The odd lifestyle ... detailed for the first time in research findings that throw new ... The Pacific leaping blenny is a marine fish yet is terrestrial ...
Cached Biology News:Lawson researchers share in $2.2 million grant 2Scientist creates new hypothesis on ocean acidification 2Landlubber fish leap for love when tide is right 2
... 2D polyacrylamide gel electrophoresis (2D-PAGE) with biological ... core technology platform for proteomic analysis. 2D-PAGE ... samples limited only in the dynamic range ... proteins. Quantitative image based analysis of separated ...
... is ideal for high-fidelity amplification of ... as cloning and mutagenesis. High ... enzyme preparation containing recombinant DNA polymerase ... Site5' exonuclease) activity. Platinum Anti-Pfx ...
... PLAU N-term Antibody This antibody is generated ... synthetic peptide selected within aa 50~150 of ... in PBS with 0.09% (W/V) sodium azide. ... G column and eluted out with both ...
...
Biology Products: